London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Steve, last year was £222k so I think £500k might be pushing it a bit even although they did say "Strong start to the 2020/21 financial year for this business, with first quarter revenues substantially ahead of the comparative quarter in 2019/20." WRT Dsm revenue.
Not long till we find out
colbaltblue, in reply to your point 1.
I agree that there will be a slight delay in payment between By-health ordering Fruitflow from DSM and the cash arriving in PXS bank account but that would depend on the payment term if any DSM give By-Health. By-Health will have to order Fruitflow before any products hit the shelves.
"If a successful blue cap health claim is achieved for Fruitflow in China it would currently be expected to result in some significant recurring orders for Fruitflow, at a multiple of current total sales values."
I assume there will be no change to the AA for By-Health purchases so would still give PXS "a multiple of current total sales values" all be it not in a one off payment.
2. For sure there will be holder selling into any rise, especially ones who got in at the lows. Volume is low but you only need to look back a few weeks when FF+ in China was announced to see what an increase in volume can do to the SP.
All IMO though.
Steve. In order to progress that patent to a commercial health claim, an awful lot more spending on clinical testing would be necessary. Very frustrating, but it's pone of the many things I refer to when I say that cash generation could unlock so much more. ATB
Now this board feels like it is encouraging some good discussion from all sides of the fence. I would also like to pass thanks to gixer for the breadth of research to date. Colbaltblue and others comments are very valid, LTHs may see relief from the immediate lift in SP from any positive news on blue cap! What do people think the effect of posotive news on the patent filed against air polution claim? Also were do people see half year figures. Will PXS break 500k?
The priority for me is to see the company become cash generative, which would end the perennial constraint on ambition. When that happens, many things become possible, things that posters here accuse the company of not doing. I believe that the retail arm could have real potential.
DD77. Rare that a poster regards myself and Colb in the same manner !!
Yeah, errm, luv you too :-)
gixer, I'm always happy to engage with a poster who never makes this a personal issue. I regard Fruitflow as a superb product and I've been using it for many years and will continue to use it. I have always regretted the fact that it is still not as well known as it should be and that it has not been driven harder into the professional and public arena.
To respond to your points:
1) As far as I understand the announcement in 2019, By-health will have a range of Fruitflow related products available via various outlets post blue cap. We don't know much more but the indication is that trials are progressing satisfactorily. I'm assuming that the supply of FF will be acquired via DSM and therefore the share to Provexis is unknown outside of the people party to the arrangements. Therefore, the eventual benefit to the bottom line of PXS will come via an agreed distribution from DSM. This will only occur after prospective sales in China, hence the potential delay IMO.
2) More of a gut feeling but I've seen the collective sigh of relief from other "lifers" in other shares when, after many years, a SP actually begins to rise and people can recover some cash. In addition, where will the NEW buyers come from? Volumes tell me that there is little appetite for this share at the moment and AIM has changed enormously in the last 5 years. It is now very much a wild west casino for short-termers looking for a quick buck
DP64, I know its always good to have an exit strategy but with PXS I don't, not yet anyway, but I doubt very much I would be selling in "one go".
I have a few shares but far from a significant holder unfortunately.
DP64, DD77 and alfista. Thanks.
Just to say you another thanks for your wonderful research. Just matter of interest what price will you exit as you are one of the significant share holder. Are you planning to exit phase by phase or just at one go?
I am here before 2009, so longer than you. You probably very busy in checking spelling and attacking people to get an attention. Keep it up.
How ironic that alfista calls out people for conduct, given they are the chief name caller when anyone dares to question the company. He lost all credibility a long time ago.
Gixer - you are a gem keeping us informed on here, it might appear a thankless task but it provides us with a semblance of what's going on. Why PXS are not doing is, is beyond belief.
As for future valuation, it's all speculation. Noone knows how it will take off in China, if/when Blue Cap is approved. Double digits is pipedream in my opinion but not impossible. I think the SP could double next year and perhaps reach 3p but i'd expect it to be taken over in the short-medium term if it achieves Blue Cap.
I'm pleasantly surprised and encouraged that the SP is holding up, in spite of the imminent raise
Cobalt - bang on the money (pun intended!) LTH if it hits 2p I'll be at the exit door. Have got my average down to 1.79p, so it might even be before that. PXS was one of my earliest 'investments' and I recall the coca cola hype. The fact I'm still here shows how much it was a classic erroneous novice investor play. One day Rodders.... as it went back then
Agree with that on both points Gixer. I see it as a simple matter of Colb projecting his own view as that of the majority. Since no other holder has followed the same path as he did, buying at a peak, selling most of his holding at a low, leaving an unreachable average, it's more than clear that he is isolated amongst the main view. Another case of higher education creating delusions of grandeur.
There are a number of future outcomes possible, including a bid for the entire company. I don't think anyone other than the BoD have any specific knowledge of what the future may hold, but, mainly thanks to you, we can see positive developments. for me, that'll do for now. I would, however, like the sp to reach a point where the moaner leaves us. Obs :-)
although there are more shares, we have a lot more health claims cf 2009.
I think 5p would be a good result, but I’m expecting nearer 3p. Given the very large stock options the board have, this range would make them very comfortable indeed.
However if by some good fortune we go mainstream - i.e. FF adverts in middle of Corrie, then 22p would not be unreasonable for a takeover scenario and IF would get on the rich list ? lol
Hi colbaltblue, not saying you are wrong. Or right for that matter but it would be interesting to get your view on 2 of the points you make.
1. "The time to start thinking about a couple of pence is when the company makes a profit and that won't happen for years IMO."
Years is quite an open statement so not sure how you come to this conclusion.
Me. I think we will be in profit soon after By-Health gets blue Cap.
2. "there is a huge head of steam for many lifers to exit this disappointing share as soon as anything in excess of 2p is reached."
Not sure there is any evidence of long term holders saying they would sell at 2p. Many LTH could already be in profit if they had averaged down over the years but i have no idea when they will sell.
DP64, the fictitious spike of 2009/2010, I can't remember exactly when, was a brief blip which nobody managed to sell on. The spike was caused by a rumour of a deal with Coca-cola. In addition there were far less shares in issue at that time. if you want to think about a "spike" you need to revisit the time when the then CEO bailed out at approx 7p to finish his home improvements!
Any dreamer who thinks this share will get into double figures anytime soon is delusional IMO. The time to start thinking about a couple of pence is when the company makes a profit and that won't happen for years IMO. I remind you that the vast part of the current income is used up in the form of remuneration to the BOD. I know you're only a recent visitor here and have only been a member of LSE for 5 minutes displaying very little knowledge in general, but I assure you, IMO, there is a huge head of steam for many lifers to exit this disappointing share as soon as anything in excess of 2p is reached. It's almost comical that you, a newby to PXS, lecture me as I have held this share since 2009. Please do some research for a change. Read back through the accounts and check the charts but don't do it late at night. You'll have nightmares! It's not a pretty history.
Don't think this product has been posted before but no idea if its new.
GNC SCIENTIFIC NUTRITION BRAIN HEALTH FORMULA
GNC Holdings, Inc. seem to have been in a bit of trouble recently but were sold to Harbin Pharmaceutical Group.
In June 2020, the company filed for Chapter 11 bankruptcy protection and indicated plans to close at least 800 stores. Effective on June 30, 2020, the stock was delisted from the New York Stock Exchange and shifted to the OTC Pink market. In September 2020, the bankruptcy court in Delaware approved the sale of GNC for $770 million to Harbin Pharmaceutical Group
Harbin Pharmaceutical Group Co is a Chinese -based company
What does that mean? Probably SFA but I found it interesting that the Fruitflow Trade Mark licence agreement popped up in the Chapter 11
Fully agreed with your thoughts about what is mentioned in the report. I have a strong believe that we will be bought long before the full potential of fruitflow is exploited. A lots of share holder will agree below 10p a share. I am not sure what SL is thinking about his significant interest in PXS. My personal view is that we should hold it till the full potential of fruitflow is exploited as we have been holding so long and missed the last 22p spike. Those people who are too busy to check the spelling probably do not have any clue about whatever mentioned in the last PXS report.
1 pence would be a good start!!
colbaltblue, Its difficult to give future growth estimates on what we as shareholders don't know although the company has already given a clue "The total projected annual sales value of the prospective sales pipeline for Fruitflow continues to stand at a substantial multiple of existing annual sales."
As for the companies vision. "The Group's strategic priority is to focus on developing revenues from the Fruitflow business together with the Group's Alliance partner DSM, whilst also managing the relationship with DSM."
"Specialising in functional food and dietary supplements, Provexis has a clear commercial focus to deliver viable products and high quality scientific intellectual property from the laboratory through to revenue stream"
"The end game?" To make us a profitable company with at least 2 revenue streams.
£4.00 a share and 50p dividends :-) lol :-P
Not serious about the last bit BTW.
Oh looky here.
A new ID searching for a years banned ex poster.
It amazes me that as soon as there is a glimmer of hope with this share, a new name crawls out of the wood work, either to ramp or de-ramp, its actually quite laughable... Who are you people???
Cannot believe this ship is still affloat!!
Where is our friend DragoReborn and his finishing one liners?
6p soon. The train is leaving the station!
Those of us who conduct themselves with civility have as much as is needed, and none breaks any market rules. Whilst those of us who don't know how to conduct themselves with decency. Don't.
But what is the end game? Ian Ford has never shared his vision of what he wants the company to be. At the moment, the company still needs to raise funds to survive and it is possible that sufficient income will eventually bring profitability but then what? One of things I find most irksome about this forum is that nobody provides an analysis of likely scenarios. All we get is links to more products or dreamers plucking wild figures out of the air ranging from 5p to 22p. Now for once, without resorting to personal insults, can we have a sensible discussion on likely future growth which is based on best estimates because we'll never get a clue from the invisible man at the helm.